Sign in
Taking people in CroatiaNo phase

How treatment before surgery affects complications in colorectal cancer surgery

Compares complications and small blood vessels in colorectal cancer patients with and without earlier treatment.

Key facts

Who runs it
Osijek University Hospital
Where
Osijek, CroatiaSee the site
Trial code
Registry title
Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer
Status
Recruiting
People taking part
68 people, planned
Started
9 Jan 2026
Expected to end
1 May 2027
Type of study
Observational, 2 groups
Treatments tested
  • Skin and subcutaneous tissue sampling for histopathological analysis
  • Blood sampling for laboratory analyses before and after surgery
Record updated
20 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with colorectal cancer who are planned for surgery. Some have had treatment before surgery (neoadjuvant therapy) and some go straight to surgery.

Age
18 years or older
Sex
Women and men can join
Disease stage
Colorectal cancer confirmed by tissue testing. Surgery is planned, either keyhole (laparoscopic) or open. ASA class II or III.
Earlier treatment
One group has had neoadjuvant therapy before surgery. The comparison group has not had it.

Main reasons for not taking part

  • Under 18 years old
  • Cannot understand the study or give consent
  • Emergency surgery
  • Long-term corticosteroid treatment
  • Not conscious or not oriented

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Adults aged ≥18 years with histologically confirmed colorectal cancer
  • Planned surgical treatment for colorectal cancer (either laparoscopic LPSC or open laparotomy)
  • Ability to understand the study protocol and provide written informed consent
  • Both sexes
  • ASA classification II or III
  • Patients who received neoadjuvant therapy is investigational group and patients who did not receive neoadjuvant therapy is control group

Who cannot take part

  • Emergency surgical cases
  • Patients on chronic corticosteroid therapy
  • Age <18 years
  • Patients who are not conscious, not oriented, or unable to provide informed consent
  • Patients unable to understand the study protocol

Where in Croatia

  • KBC OsijekOsijek, CroatiaContact: Slavica Kvolik, Prof.PhDTaking people

About the trial

What the trial wants to find out

This prospective study investigates the effects of neoadjuvant therapy on endothelial function, microvascular tissue density, and tissue fibrosis in patients with colorectal cancer and their association with perioperative complications. The primary objective is to assess differences in microvascular tissue density between patients who received neoadjuvant therapy and those who did not, biomarkers, and demographic factors between patients who received neoadjuvant therapy and those who underwent surgery as initial treatment, and to compare clinical outcomes. The study will include 34 patients treated with neoadjuvant therapy and 34 patients for whom surgery is the first-line treatment. Patients will be followed until discharge from the hospital, and complications after discharge will be monitored through medical records one month after surgery.

The 2 groups in the trial

  • Patients who received neoadjuvant therapy.

    The study will include 34 consecutive patients undergoing colorectal cancer surgery who received neoadjuvant therapy.

    Treatment: Skin and subcutaneous tissue sampling for histopathological analysis and Blood sampling for laboratory analyses before and after surgery

  • Patients who did not receive neoadjuvant therapy, control group.

    The control group will include 34 patients undergoing colorectal cancer surgery who have not received neoadjuvant therapy.

    Treatment: Skin and subcutaneous tissue sampling for histopathological analysis and Blood sampling for laboratory analyses before and after surgery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Impact of Neoadjuvant Therapy on Perioperative Complications and Treatment Outcomes in Patients Undergoing Colorectal Cancer Resection
Plain-language title
How treatment before surgery affects complications in colorectal cancer surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
20 February 2026